XML 86 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Data (Tables)
 12 Months Ended
Dec. 31, 2017
Quarterly Financial Data [Abstract]  
Schedule of Quarterly Financial Information
The following table presents unaudited quarterly consolidated operating results for each of our last ten quarters. The information below has been prepared on a basis consistent with our audited consolidated financial statements (in millions, except per share amounts).
Year Ended December 31, 2017
First
Quarter (2)
 
Second
Quarter (3)
 
Third
Quarter (4)
 
Fourth
Quarter (5)
Net sales
$
1,194.0

 
$
1,237.9

 
$
1,231.3

 
$
1,283.0

Gross profit
$
464.4

 
$
504.6

 
$
497.8

 
$
512.7

Change in financial assets
$
(17.1
)
 
$
38.7

 
$
2.6

 
$
0.7

Net income (loss)
$
71.6

 
$
(69.6
)
 
$
44.5

 
$
73.1

Earnings (loss) per share(1):
 
 
 
 
 
 
 
Basic
$
0.50

 
$
(0.49
)
 
$
0.31

 
$
0.52

Diluted
$
0.50

 
$
(0.49
)
 
$
0.31

 
$
0.52

Weighted average shares outstanding
 
 
 
 
 
 
 
Basic
143.4

 
143.3

 
141.3

 
140.8

Diluted
143.6

 
143.3

 
141.7

 
141.2


(1)    The sum of individual per share amounts may not equal due to rounding.
(2) 
Includes IPR&D impairment charges of $12.2 million, gain on certain divestiture of $21.8 million, and restructuring charges of $38.7 million.
(3) 
Includes intangible asset impairment charges of $18.5 million, changes in financial assets of $38.7 million, and loss on early debt extinguishment of $135.2 million.
(4) 
Includes held-for-sale impairment charges of $3.3 million, and fixed asset impairment charges of $4.0 million.
(5)  
Includes unusual litigation charge reversal of $0.2 million.
Year Ended December 31, 2016
First
Quarter (2)
 
Second
Quarter (3)
 
Third
Quarter (4)
 
Fourth
Quarter (5)
Net sales
$
1,347.3

 
$
1,340.5

 
$
1,261.6

 
$
1,331.2

Gross profit
$
533.1

 
$
546.5

 
$
484.5

 
$
487.7

Change in financial assets
$
204.4

 
$
910.8

 
$
377.4

 
$
1,115.6

Net loss
$
(529.2
)
 
$
(534.3
)
 
$
(1,590.2
)
 
$
(1,359.1
)
Loss per share(1):
 
 
 
 
 
 
 
Basic
$
(3.70
)
 
$
(3.73
)
 
$
(11.10
)
 
$
(9.48
)
Diluted
$
(3.70
)
 
$
(3.73
)
 
$
(11.10
)
 
$
(9.48
)
Weighted average shares outstanding
 
 
 
 
 
 
 
Basic
143.2

 
143.2

 
143.3

 
143.4

Diluted
143.2

 
143.2

 
143.3

 
143.4



(1)    The sum of individual per share amounts may not equal due to rounding.
(2) 
Includes an intangible asset impairment charges of $273.3 million, and a goodwill impairment charge of $130.5 million.
(3) 
Includes held-for-sale impairment charges of $10.5 million and change in financial assets of $910.8 million.
(4) 
Includes intangible asset impairment charges of $866.6 million, goodwill impairment charge of $737.9 thousand, and held-for-sale impairment charges of $10.2 million.
(5)  
Includes intangible asset impairment charges of $378.6 million, goodwill impairment charge of $224.1 million, and a reduction in held-for-sale impairment charges of $4.5 million.

Six Months Ended December 31, 2015
September 26, 2015 (2)
 
December 31, 2015 (3)
Net sales
$
1,273.1

 
$
1,359.1

Gross profit
$
535.2

 
$
543.7

Change in financial assets
$
(173.8
)
 
$
116.6

Net income (loss)
$
260.9

 
$
(218.4
)
Earnings (loss) per share(1):
 
 
 
Basic
$
1.78

 
$
(1.51
)
Diluted
$
1.78

 
$
(1.51
)
Weighted average shares outstanding
 
 
 
Basic
146.3

 
144.9

Diluted
146.9

 
144.9



(1) 
The sum of individual per share amounts may not equal due to rounding.
(2) 
Includes Mylan defense-related fees of $15.6 million.
(3) 
Includes an intangible asset impairment charge of $185.1 million, Mylan defense-related fees of $71.3 million, an impairment charge on our India API held for sale assets of $29.0 million, restructuring charges of $24.7 million, and an investment impairment charge of $10.7 million.